New hope for lymphoma patients: drug combo shows promise in early trial
NCT ID NCT07029737
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 3 times
Summary
This study tests a new drug called acalabrutinib combined with standard chemotherapy (R-CHOP) in people with untreated mantle cell lymphoma who cannot have a stem cell transplant. The goal is to see how well the combination shrinks tumors and how safe it is. Participants will continue taking acalabrutinib long-term to keep the cancer under control, but this is not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGA Coruña, 15006, Spain
-
Research Site
RECRUITINGAlcorcón, 28922, Spain
-
Research Site
RECRUITINGBadalona, 08916, Spain
-
Research Site
RECRUITINGBarcelona, 08035, Spain
-
Research Site
RECRUITINGBarcelona, 08036, Spain
-
Research Site
RECRUITINGBurgos, 09006, Spain
-
Research Site
RECRUITINGDonostia / San Sebastian, 20014, Spain
-
Research Site
RECRUITINGGijón, 33206, Spain
-
Research Site
RECRUITINGMadrid, 28005, Spain
-
Research Site
RECRUITINGMadrid, 28006, Spain
-
Research Site
RECRUITINGMadrid, 28007, Spain
-
Research Site
RECRUITINGMadrid, 28029, Spain
-
Research Site
WITHDRAWNMajadahonda, 28222, Spain
-
Research Site
RECRUITINGMálaga, 29010, Spain
-
Research Site
RECRUITINGPalma de Mallorca, 07198, Spain
-
Research Site
RECRUITINGSalamanca, 37007, Spain
-
Research Site
RECRUITINGSanta Cruz de Tenerife, 38010, Spain
-
Research Site
RECRUITINGSantander, 39008, Spain
-
Research Site
RECRUITINGSeville, 41013, Spain
-
Research Site
RECRUITINGValencia, 46010, Spain
-
Research Site
RECRUITINGValencia, 46017, Spain
-
Research Site
RECRUITINGVigo, 36214, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Can a targeted drug boost standard chemo for a rare blood cancer?
- Smartwatches track hidden heart risk in blood cancer patients